Description
Founded in 1987, Knoll Capital Management is a venture capital investment firm based in New York, New York. The firm prefers to invests in firms focused in information technology and Life Sciences & Healthcare sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Exicure | 22-Aug-2018 | PIPE | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
00000000000 | 29-Nov-2017 | 00000 00000 | 000.00 | Other Devices and Supplies | Generating Revenue/Not Profitable | |
0000000 | 06-Nov-2017 | 0000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
00000000 | 16-Feb-2017 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | |
000000 00000000000 | 01-Jun-2015 | 0000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
0000000 0000000000 | 15-Jan-2015 | 0000 | 00.000 | Drug Discovery | Clinical Trials - Phase 2 | |
Synthetic Biologics | 29-Oct-2012 | PIPE | 000.00 | Drug Discovery | Generating Revenue | |
ATP Oil & Gas | 10-Dec-2004 | PIPE | 0000 | Media and Information Services (B2B) | Bankruptcy: Liquidation |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
electroCore | 22-Jun-2018 | IPO | 0000 |
00000000 | 04-May-2017 | 000 | 00000 |
000000 00000000000 | 28-Oct-2016 | 000000 0000000000 | 0000 |
0000000 | 25-Oct-2013 | 000000 0000000000 | 0000 |
000 000 & 000 | 01-Oct-2013 | 0000000000: 000000 | |
000000000 00000000 | 31-Dec-2012 | 000000000 00000000 | |
000 000 & 000 | 24-Sep-2009 | 000000 0000000000 | 0000 |
ATP Oil & Gas | 15-Nov-2007 | Public Investment 2nd Offering | 00000 |
Aldeyra Therapeutics | Secondary Transaction - Open Market |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Patrick O'Neill | Chief Operating Officer | New York, NY | |||
Fred Knoll | Founder, Principal, President & Portfolio Manager | 0 | New York, NY | ||
Karina Knoll | Analyst | New York, NY |